Goz Vadim, Lakomkin Nikita, Jalali Ali, Brodke Darrel S, Spiker William R
University of Utah, Salt Lake City, UT, USA.
Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Global Spine J. 2019 Apr;9(2):138-142. doi: 10.1177/2192568218764677. Epub 2018 Jul 31.
Retrospective review.
To determine whether abnormal preoperative testing is associated with postoperative complications in patients undergoing a microdiscectomy.
Patients undergoing a microdiscectomy between 2006 and 2013 were identified in the National Surgical Quality Improvement Program database based on appropriate current procedural terminology coding. Thirty-day postoperative complications were analyzed in addition to patient demographics, comorbidities, and abnormal preoperative laboratory values. A series of over 650 univariate analyses to determine which independent variables to include for each complication were completed. Based on those analyses, 12 logistic regression models were built, one for each specific complication. Each model adjusted for age, gender, comorbidities, American Society of Anesthesiologists classification, as well as operative time.
A total of 5947 patients undergoing a microdiscectomy were included in the study. Abnormal preoperative international normalized ratio (odds ratio [OR] = 5.85, < .05) was associated with any wound infection, superficial or deep, and abnormal partial thromboplastin time was significantly associated with wound dehiscence (OR = 6.80, < .05). Postoperative urinary tract infections were associated with abnormal preoperative hematocrit (OR = 8.00, < .05). None of the identified preoperative labs were independently associated with pulmonary embolism, organ space surgical site infections, or intubation.
Abnormal preoperative coagulation labs were significantly associated with postoperative wound complications. However, the majority of tests were not associated with adverse events following microdiscectomy. Further study is necessary to conclude whether these tests provide information that can modify perioperative management and whether widespread testing is cost-effective.
回顾性研究。
确定在接受显微椎间盘切除术的患者中,术前检查异常是否与术后并发症相关。
基于适当的当前手术操作术语编码,在国家外科质量改进计划数据库中识别出2006年至2013年间接受显微椎间盘切除术的患者。除了患者人口统计学、合并症和术前实验室值异常外,还分析了术后30天的并发症。完成了一系列超过650次的单变量分析,以确定每种并发症应纳入哪些独立变量。基于这些分析,建立了12个逻辑回归模型,每种特定并发症对应一个模型。每个模型都对年龄、性别、合并症、美国麻醉医师协会分级以及手术时间进行了调整。
共有5947例接受显微椎间盘切除术的患者纳入本研究。术前国际标准化比值异常(比值比[OR]=5.85,P<.05)与任何浅表或深部伤口感染相关,部分凝血活酶时间异常与伤口裂开显著相关(OR=6.80,P<.05)。术后尿路感染与术前血细胞比容异常相关(OR=8.00,P<.05)。所确定的术前实验室检查均与肺栓塞、器官腔隙手术部位感染或插管无独立相关性。
术前凝血实验室检查异常与术后伤口并发症显著相关。然而,大多数检查与显微椎间盘切除术后的不良事件无关。需要进一步研究以确定这些检查是否能提供可改变围手术期管理的信息,以及广泛检查是否具有成本效益。